Defining Dysbiosis in Patients with Urolithiasis

Abstract The prevalence of urinary stone disease (USD) is rapidly rising. However, the factors driving this increase are unknown. Recent microbiome studies suggest that dysbiosis may in part contribute to the increasing prevalence. The objective of the current study was to determine the nature and l...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anna Zampini, Andrew H. Nguyen, Emily Rose, Manoj Monga, Aaron W. Miller
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4965c2a35cb1470c8dcf88bc26c366de
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4965c2a35cb1470c8dcf88bc26c366de
record_format dspace
spelling oai:doaj.org-article:4965c2a35cb1470c8dcf88bc26c366de2021-12-02T15:08:46ZDefining Dysbiosis in Patients with Urolithiasis10.1038/s41598-019-41977-62045-2322https://doaj.org/article/4965c2a35cb1470c8dcf88bc26c366de2019-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-41977-6https://doaj.org/toc/2045-2322Abstract The prevalence of urinary stone disease (USD) is rapidly rising. However, the factors driving this increase are unknown. Recent microbiome studies suggest that dysbiosis may in part contribute to the increasing prevalence. The objective of the current study was to determine the nature and location of dysbiosis associated with USD. We conducted microbiome analysis from the gastrointestinal and urinary tracts, along with a metabolomic analysis of the urinary metabolome, from subjects with an active episode of USD or no history of the disease. Higher rates of antibiotic use among USD patients along with integrated microbiome and metabolomic results support the hypothesis that USD is associated with an antibiotic-driven shift in the microbiome from one that protects against USD to one that promotes the disease. Specifically, our study implicates urinary tract Lactobacillus and Enterobacteriaceae in protective and pathogenic roles for USD, respectively, which conventional, culture-based methods of bacterial analysis from urine and kidney stones would not necessarily detect. Results suggest that antibiotics produce a long-term shift in the microbiome that may increase the risk for USD, with the urinary tract microbiome holding more relevance for USD than the gut microbiome.Anna ZampiniAndrew H. NguyenEmily RoseManoj MongaAaron W. MillerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-13 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Anna Zampini
Andrew H. Nguyen
Emily Rose
Manoj Monga
Aaron W. Miller
Defining Dysbiosis in Patients with Urolithiasis
description Abstract The prevalence of urinary stone disease (USD) is rapidly rising. However, the factors driving this increase are unknown. Recent microbiome studies suggest that dysbiosis may in part contribute to the increasing prevalence. The objective of the current study was to determine the nature and location of dysbiosis associated with USD. We conducted microbiome analysis from the gastrointestinal and urinary tracts, along with a metabolomic analysis of the urinary metabolome, from subjects with an active episode of USD or no history of the disease. Higher rates of antibiotic use among USD patients along with integrated microbiome and metabolomic results support the hypothesis that USD is associated with an antibiotic-driven shift in the microbiome from one that protects against USD to one that promotes the disease. Specifically, our study implicates urinary tract Lactobacillus and Enterobacteriaceae in protective and pathogenic roles for USD, respectively, which conventional, culture-based methods of bacterial analysis from urine and kidney stones would not necessarily detect. Results suggest that antibiotics produce a long-term shift in the microbiome that may increase the risk for USD, with the urinary tract microbiome holding more relevance for USD than the gut microbiome.
format article
author Anna Zampini
Andrew H. Nguyen
Emily Rose
Manoj Monga
Aaron W. Miller
author_facet Anna Zampini
Andrew H. Nguyen
Emily Rose
Manoj Monga
Aaron W. Miller
author_sort Anna Zampini
title Defining Dysbiosis in Patients with Urolithiasis
title_short Defining Dysbiosis in Patients with Urolithiasis
title_full Defining Dysbiosis in Patients with Urolithiasis
title_fullStr Defining Dysbiosis in Patients with Urolithiasis
title_full_unstemmed Defining Dysbiosis in Patients with Urolithiasis
title_sort defining dysbiosis in patients with urolithiasis
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/4965c2a35cb1470c8dcf88bc26c366de
work_keys_str_mv AT annazampini definingdysbiosisinpatientswithurolithiasis
AT andrewhnguyen definingdysbiosisinpatientswithurolithiasis
AT emilyrose definingdysbiosisinpatientswithurolithiasis
AT manojmonga definingdysbiosisinpatientswithurolithiasis
AT aaronwmiller definingdysbiosisinpatientswithurolithiasis
_version_ 1718387995396014080